|
Product complaint # (b)(4).Date sent to the fda: 8/21/2025.H6 component code: g07002 - no device problem found.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.A manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified.Additional information was requested the following was obtained: please provide an answer for each patient-event: (b)(4) captures the initial report for ".The issue has reported and additional same event as (b)(4).It was found that the suture had been frayed, the suture was broken." (b)(4) captures the ambiguous multiple event report.- please confirm the number of patient-event affected by this alleged deficiency.Unk.- have any of these events been previously reported to ethicon? if so, provide the respective reference number(s).If not, please create a new pc file for each patient-event.Unk.- when did the suture fray occur? (e.G., during removal from the package, during handling prior to use on the patient, during passage through tissue, during tying, or post-operation?) unk.- how many sutures frayed? unk.- when did the suture breakage occurred (removal from package / during handling prior to use on patient/ during passage through tissue / during tying / post-op)? unk.- how many sutures broke? unk.- please perform and document the follow up attempt for product return.Please document the shipment tracking number in notes or rmao sections.The device has been received at sukagawa and will be shipped.Please check rmao.Tracking nukber: (b)(4).- provide the source or name and title of external person providing answers to follow-up (external person submitting answers to sales rep or loc/bq).(b)(4).The quantity will be changed all seven boxes as defective products due to arrange replacement products because all products were approved for replacement as complaints on 29th july.The customer requested to inspect all 7 boxes.One box and the six unopened boxes had all been placed in the same box and sent to sukagawa qa.The customer requested to return the unopened 6 boxes instead of the usual replacement when the sales rep checked regarding the arrangement of replacement products.However, since the unopened 6 boxes have already been shipped, the sales rep is reconfirming how to deliver it from qa.The following information was reported: although replacement products were sent from the sales office, but the same problem occurred with the replacement products.The customer has requested a replacement product other than the lot in question due to these events.Regarding the quantity, the sales rep is currently checking if the product number is exactly 7 boxes as reported.H3 investigational summary: the product was returned to ethicon for evaluation.Eighty-six representative unopened samples were received for analysis.Product code j506g.Following the sampling plan, a visual inspection was conducted on thirteen samples.The packets were open, and the swage and attachment area were noted to be as expected.The sutures were dispensed without problems and examined along the strand and open braid could be observed on two strands.Due to this inconsistency, the remaining seventy-three samples were dispensed and examined along the strand and open braid could be observed seven strands.On the remaining sixty-four samples, no anomalies or issues related to the open braid or broken suture were detected during the evaluation.The functional test was performed using instron equipment, and tensile strength were above the minimum requirements.Based on the information currently available, open braid was identified during the investigation of the samples received.This product issue will be addressed through the quality system.Additional complaint information monitoring for potential safety signals will be conducted through complaint trending as part of post-market surveillance.H3 investigational summary: the product was returned to ethicon for evaluation.One needle-suture outside its packaging was received for analysis.Product code j506g.In order to evaluate the condition of the returned sample, the swage and attachment area were noted to be as expected.The suture was examined along the strand and, no anomalies or issues related to the open braid or broken suture were detected during the evaluation.The product code j506g contains an absorbable suture.As the sample was received open, the time of exposure to the environment cannot be determined.As per the condition of the returned sample, the functional test could not be performed.As part of the ethicon quality process, all devices are manufactured, inspected, and released to approved specifications.The event described could not be confirmed as no product defect was identified, there may have been other circumstances or issues that occurred during the use of the device that could not be replicated during the laboratory analysis.Additional complaint information monitoring for potential safety signals is conducted through complaint trending as part of post-market surveillance.
|
|
It was reported that a patient underwent an unknown procedure on an unknown date and suture was used.During an unknown surgery, it was found that the suture had been frayed, the suture was broken and there were concerns about the tensile strength due to absorbable sutures.Although they have used a large amount until now, but they think that these products are defective.The same events continued when the package was opened, so the customer requests an exchange and investigation.It was not a control release needle.Another product was used to complete the case.There were no adverse consequences to the patient.Additional information was requested.
|